Legend Biotech interim CEO Alan Bash files initial beneficial ownership statement

PUBT · 1d ago
Legend Biotech interim CEO Alan Bash files initial beneficial ownership statement
  • Legend Biotech interim CEO Alan Bash filed an initial Form 3 disclosing 30,234 ordinary shares, including 13,092 RSUs vesting Dec. 20, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001908421-26-000004), on August 03, 2026, and is solely responsible for the information contained therein.